Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease [clinicaltrials:NCT00367913]
Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease [clinicaltrials:NCT00367913]
Bio2RDF identifier
NCT00367913
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00367913
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
To date key drugs in th ...... immunotherapy with M.vaccae.
brief title [clinicaltrials_vocabulary:brief-title]
Clarithromycin v Ciprofloxacin ...... ycobacterial Pulmonary Disease
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2004-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2006-08-21T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Ciprofloxacin
Clarithromycin
Pulmonary diseases caused by Opportunist Mycobacteria
Treatment of Opportunist Mycobacteria
pulmonary disease
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2006-08-21T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00367913
official title [clinicaltrials_vocabulary:official-title]
Treatment of Pulmonary Disease ...... of Immunotherapy With M.Vaccae
org study id [clinicaltrials_vocabulary:org-study-id]
BTS Opportunist Mycobacteria
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1995-03-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2006-07-01T00:00:00Z
identifier
clinicaltrials:NCT00367913
title
Clarithromycin v Ciprofloxacin ...... ycobacterial Pulmonary Disease
@en
type
label
Clarithromycin v Ciprofloxacin ...... e [clinicaltrials:NCT00367913]
@en